Wavelength is a customer-focused developer and manufacturer of Active Pharmaceutical Ingredients (APIs). On Demand Pharmaceuticals is a manufacturing technology company that will allow medicines to be made in small machines anywhere. The US-Israel Binational .Industrial Research & Development (BIRD) Foundation is investing $1M to advance the development and pilot of an on-demand medicine manufacturing system. Wavelength Pharmaceuticals and On Demand Pharmaceuticals will leverage their complementary manufacturing capabilities to strengthen a reliable supply of essential medicines and the ingredients required to make them.
Read the recent press release on the collaboration.
About On Demand Pharmaceuticals
On Demand Pharmaceuticals™ is an innovative technology company transforming how medicines are made so they can be produced on demand—whenever and wherever medicines are needed. On Demand’s breakthrough manufacturing technology platform, the Pharmacy on Demand (PoD)™, can be quickly customized to produce anything from key starting materials to active pharmaceutical ingredients (API), and final formulated drugs. With this technology, the company is on a mission to provide an adequate, safe, and reliable supply of medicines to every community across the world. For additional information, visit https://ondemandpharma.com.
About Wavelength Pharmaceuticals
Wavelength Pharmaceuticals is a customer-focused, world-class developer and manufacturer of Active Pharmaceuticals Ingredients with more than 35 years of exceptional regulatory track record. Its recent merger with SEQENS has created a scaled leader of global industrial footprint and one of the world’s leading providers of pharmaceutical solutions with annual revenues of $1.3 billion, 24 manufacturing sites, 10 R&D centres and 3,200 employees worldwide. The combined company has a broad portfolio of products with more than 200 active pharmaceutical ingredients, 500 drug intermediates, as well as pharmaceutical grade solvents and specialty ingredients. The company offers a wide range of API custom development and manufacturing services across a wide range of advanced technology platforms including enzymatic chemistry, particle design, spray drying, custom polymers, lipids, highly potent and controlled substances. From pre-clinical grams to multi-ton commercial scale with uncompromising consistent quality, regulatory compliance and exceptional customer service. For additional information, visit https://wavelengthpharma.com.